T-Cell Depleted RIC Allogeneic Stem Cells Transplantation: A Platform for Immunotherapy

被引：0
|
作者：
Raymakers, R. [1 ]
Levenga, H. [1 ]
Schattenberg, T. [1 ]
Maas, F. [1 ]
Esendam, B. [1 ]
Fredrix, H. [1 ]
de Witte, T. [1 ]
Dolstra, H. [1 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands
来源：
CLINICAL LYMPHOMA & MYELOMA | 2009年 / 9卷
关键词：
D O I：
10.1016/S1557-9190(11)70497-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [1] A retrospective Dutch study comparing T-cell depleted allogeneic blood stem cell transplantation vs T-cell depleted allogeneic bone marrow transplantation
    Cornelissen, JJ
    Fibbe, WE
    Schattenberg, AVMB
    Petersen, EJ
    Willemze, R
    de Witte, TJM
    Lijwenberg, B
    Verdonck, LF
    Van der Biezen, A
    Brand, R
    TRANSFUSION SCIENCE, 1998, 19 (03): : 196 - 197
  • [2] Allogeneic T-cell depleted blood stem cell transplantation versus T-cell depleted bone marrow transplantation: a prospective randomized multicenter study
    Cornelissen, J
    Verdonck, L
    Van der Holt, B
    Petersen, E
    Schouten, H
    Russel, L
    Vindelov, L
    Hoglund, M
    Maertens, J
    Maertens, J
    Boogaerts, M
    Lowenberg, B
    BONE MARROW TRANSPLANTATION, 2003, 31 : S40 - S40
  • [3] Complications after T-CELL depleted allogeneic hematopoietic stem cell transplantation (HSCT).
    Bieri, S
    Roosnek, E
    Helg, C
    Ozsahin, H
    Wacker, P
    Chapuis, B
    Miralbell, R
    Chalandon, Y
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 141 - 141
  • [4] Allogeneic transplantation of T-cell depleted stem cell grafts followed by T-cell add back.
    Weber-Nordt, RM
    Goldschmidt, H
    Thalheimer, M
    Fruehauf, S
    Goerner, M
    Ho, AD
    BLOOD, 2000, 96 (11) : 399A - 399A
  • [5] Regulatory T-cell immunotherapy for allogeneic hematopoietic stem-cell transplantation
    Horch, Matthew
    Nguyen, Vu H.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (01) : 29 - 44
  • [6] Cytomegalovirus infection following T-cell depleted allogeneic stem cell transplantation: comparison between two different methods of T-cell depleted
    Chakrabarti, S
    Milligan, D
    Brown, J
    Pamphilon, D
    Osman, H
    Marks, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S92 - S92
  • [7] Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation
    Baron, F
    Beguin, Y
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (07) : 351 - 359
  • [8] Improved outcome after T-cell depleted allogeneic hematopoietic stem cell transplantation for myelofibrosis
    Simonetta, F.
    Casini, A.
    Wilk, M.
    Ecsedi, M.
    Andres, M.
    Gerull, S.
    Masouridi-Levrat, S.
    Beauverd, Y.
    Mohty, B.
    Bucher, C.
    Stern, M.
    Manz, M.
    Nair, G.
    Schanz, U.
    Passweg, J.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S292 - S292
  • [9] Non-myeloablative in vitro T-cell depleted allogeneic stem cell transplantation is a good platform for subsequent cellular immunotherapy in patients with hematological malignancies and solid tumors
    Barge, RMY
    Marijt, WAF
    Osanto, S
    Starrenburg, CWJ
    Smit, W
    Fibbe, WE
    Falkenburg, JHF
    Willemze, R
    BONE MARROW TRANSPLANTATION, 2003, 31 : S150 - S151
  • [10] Adoptive immunotherapy with donor lymphocyte infusions after T-cell depleted allogeneic stem cell transplantation for patients with acute myeloid leukemia
    Barge, RMY
    Steel, E
    Starrenburg, I
    Beaumont, F
    Smit, WM
    Schaafsma, MR
    Posthuma, W
    Fibbe, WE
    Falkenburg, F
    Willemze, R
    BLOOD, 2005, 106 (11) : 570A - 570A
12345